Peng Xing

Shenyang, 110001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Retraction notice to "Expression characteristics of TBC1D4 activating protein molecule and identification of key module genes for preventing thyroid cancer progression" [Int. J. Biol. Macromol. 278 (2024) 134986].

Retraction notice to "Expression characteristics of TBC1D4 activating protein molecule and identification of key module genes for preventing thyroid cancer progression" [Int. J. Biol. Macromol. 278 (2024) 134986].

Journal: International journal of biological macromolecules

Published: July 29, 2026

Engineering chitosan-functionalized liposomes for targeted drug delivery and biomedical applications.

Engineering chitosan-functionalized liposomes for targeted drug delivery and biomedical applications.

Journal: International journal of biological macromolecules

Published: August 28, 2025

Expression characteristics of TBC1D4 activating protein molecule and identification of key module genes for preventing thyroid cancer progression.

Expression characteristics of TBC1D4 activating protein molecule and identification of key module genes for preventing thyroid cancer progression.

Journal: International journal of biological macromolecules

Published: June 27, 2024

Treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs.

Treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: June 14, 2023

Nuclear isoform of RAPH1 interacts with FOXQ1 to promote aggressiveness and radioresistance in breast cancer.

Nuclear isoform of RAPH1 interacts with FOXQ1 to promote aggressiveness and radioresistance in breast cancer.

Journal: Cell death & disease

Published: April 05, 2023

ZNF33A Promotes Tumor Progression and BET Inhibitor Resistance in Triple-Negative Breast Cancer.

ZNF33A Promotes Tumor Progression and BET Inhibitor Resistance in Triple-Negative Breast Cancer.

Journal: The American journal of pathology

Published: February 19, 2022

Construction and validation of a gene signature related to bladder urothelial carcinoma based on immune gene analysis.

Construction and validation of a gene signature related to bladder urothelial carcinoma based on immune gene analysis.

Journal: BMC cancer

Published: December 27, 2021

Cancer-associated adipocytes release FUCA2 to promote aggressiveness in TNBC.

Cancer-associated adipocytes release FUCA2 to promote aggressiveness in TNBC.

Journal: Endocrine-related cancer

Published: November 28, 2021

Mcl-1 inhibition overcomes BET inhibitor resistance induced by low FBW7 expression in breast cancer.

Mcl-1 inhibition overcomes BET inhibitor resistance induced by low FBW7 expression in breast cancer.

Journal: Journal of cellular and molecular medicine

Published: November 08, 2021

Identification of a novel lipid metabolism-related gene signature within the tumour immune microenvironment for breast cancer.

Identification of a novel lipid metabolism-related gene signature within the tumour immune microenvironment for breast cancer.

Journal: Lipids in health and disease

Published: October 18, 2021

LncRNA RHPN1-AS1 accelerates proliferation, migration, and invasion via regulating miR-485-5p/BSG axis in hepatocellular carcinoma.

LncRNA RHPN1-AS1 accelerates proliferation, migration, and invasion via regulating miR-485-5p/BSG axis in hepatocellular carcinoma.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: March 11, 2020

Long Non-coding RNA LOXL1-AS1 Drives Breast Cancer Invasion and Metastasis by Antagonizing miR-708-5p Expression and Activity.

Long Non-coding RNA LOXL1-AS1 Drives Breast Cancer Invasion and Metastasis by Antagonizing miR-708-5p Expression and Activity.

Journal: Molecular therapy. Nucleic acids

Published: July 29, 2019

Showing 1-12 of 23

Last Updated: 09/26/2026